Backs FY25 revenue view $10.7B-$10.85B, consensus $10.78B. Backs FY25 capital expenditures $500M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DGX:
- Quest Diagnostics reports Q1 adjusted EPS $2.21, consensus $2.15
- Is DGX a Buy, Before Earnings?
- Quest Diagnostics price target raised to $198 from $190 at BofA
- Quest Diagnostics launches AD-Detect blood test for Alzheimer’s confirmation
- Quest Diagnostics price target raised to $189 from $178 at Mizuho